✓
Open
18 Jun 2026
✓
Close
22 Jun 2026
3
Allotment
—
✓
Listing
Thu, Jun 25, 2026
Price Band
₹196 to ₹208
Issue Size
14,53,800 shares (agg. up to ₹30 Cr)
Lot Size
600 Shares
Listing Date
Thu, Jun 25, 2026
Latest GMP
₹145
Est. Gain
69.71%
✦ AI Insight
GMP Trend
25-06-2026₹145Est. ₹353+69.71%
24-06-2026₹145Est. ₹353+69.71%
23-06-2026₹95Est. ₹303+45.67%
22-06-2026₹72Est. ₹280+34.62%
21-06-2026₹70Est. ₹278+33.65%
20-06-2026₹85Est. ₹293+40.87%
19-06-2026₹85Est. ₹293+40.87%
Live Subscription
| Category | Subscription (times) |
|---|---|
| QIB | 196.77x |
| NII | 597.23x |
| Retail | 401.36x |
| Total | 270.19x |
Restated Financials (₹ Cr.)
| Period Ended | 31 Jan 2026 | 31 Mar 2025 | 31 Mar 2024 |
|---|---|---|---|
| Assets | 66.07 | 56.52 | 34.65 |
| Total Income | 41.94 | 45.97 | 24.37 |
| Profit After Tax | 5.74 | 7.23 | 2.14 |
| EBITDA | 10.34 | 11.41 | 4.08 |
| NET Worth | 28.52 | 22.78 | 6.21 |
| Reserves and Surplus | 24.49 | 18.75 | 2.93 |
| Total Borrowing | 26.73 | 22.16 | 15.13 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Anthem Biosciences Ltd. | Mainboard | ₹3,395.00 Cr | ₹570 | 70.62 | ₹730.35 | +28.13% | ₹778.90 (-1.69%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Part finances the capital expenditure towards setting up of a new manufacturing unit at industrial plot no. 70, Sector 28 in the Medical Device Park under the Yamuna Expressway Industrial Development Authority (YEIDA), Gautam Buddha Nagar, Uttar Pradesh | 14.05 |
| 2 | Funding the working capital requirements of the Company | 8.25 |
| 3 | General Corporate Purposes | 3.97 |
| 4 | Public Issue Expenses | 3.97 |
| Total | 30.24 |
About Avience Biomedicals IPO
Incorporated in June 2024, Avience Biomedicals Limited is an ISO certified company specializing in manufacturing, supplying, and exporting molecular diagnostic solutions, focusing on biotechnology, genomics, and the IVD industry. Avience Biomedicals Limited has expanded its product range from IVD rapid test kits to a comprehensive line of medical devices, including serology products and biochemistry analyzers. This demonstrates a commitment to diverse healthcare needs, focusing exclusively on the B2B and B2G markets. The company's products cater to Pathology Labs, Microbiology Labs, Hospitals, and Research Centers nationwide as well as overseas. In addition to manufacturing, the Company also act as distributors and traders of medical equipment. The company's manufacturing unit is situated in Noida, Uttar Pradesh. The company offers a comprehensive range of diagnostic solutions, including: Rapid Test Kits: Products like AVISURE Dengue Combo Test, Malaria Rapid Test (Pf/Pv), and AVISURE Syphilis Rapid Test. Biochemistry Analyzers and Reagents: Devices like the BS-240 Fully Auto Analyzer and reagents like AVIENBIO Albumin Kit. Molecular Diagnostics: COVID-19 detection kits, including
Contact Details
Avience Biomedicals Ltd. AddressC-11, Block-CCommunity CentreJanakpuri A-3Delhi, New Delhi, 1100581800-12-04-636info@avienbio.comVisit Website